武汉光谷中源药业

Wuhan Optics Valley Zhongyuan Pharmaceutical is a biotechnology company based in Wuhan, China, specializing in the development and industrialization of cell-based therapies. As a key subsidiary of Vcanbio Cell & Gene Engineering, the company focuses on mesenchymal stem cell (MSC) treatments for various inflammatory and degenerative conditions. Its lead programs include human umbilical cord mesenchymal stem cell injections targeting indications such as liver cirrhosis and lupus nephritis. The company operates within the Wuhan East Lake High-tech Development Zone (Optics Valley) and maintains advanced manufacturing facilities for clinical-grade cell products. It plays a central role in the parent company's strategy to establish a comprehensive cell therapy value chain in Central China.